A Study to Compare the Bioavailability of JNJ-47910382 Formulated as a Tablet and as Suspension in Healthy Participants

NCT01662661 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: JNJ-47910382 (suspension)
DRUG: JNJ-47910382 (tablet)

Sponsor

Janssen R&D Ireland